CAS: 63897-12-1; 2,4-Dichloro-6-Methyl-3-Nitropyridine

该化合物是一种有机化合物,其特征是其环,这是一个六人组成的芳香热循环,含有一个氮原子,该化合物有两氯原子和一个与环相连的硝基体组,有助于其反应和在各种化学工艺中的潜在应用.该甲基组的存在增强了其亲脂性,而硝基组则可以作为进一步化学修改的功能处理器.该化合物在室温中一般为固体,在有机溶剂中表现出中等溶解性.该化合物在农用化学和制药领域很受关注,可以用作合成复杂分子的中间体.安全数据表明,应当谨慎处理该化合物,因为它可能对接触健康造成危害.适当的储存和处理程序对于减轻与该化学品有关的任何潜在危害至关重要.

结构式图片

相似化合物

56057-19-3 5975-12-2 282102-05-0

欧盟法规

C&L通报

上下游产品

CAS号4966-90-9 4-羟基-6-甲基-3-硝基-2-吡啶醇 | CAS号675-10-5 6-甲基-4-羟基-2-吡喃酮 | CAS号3749-51-7 2,4-二羟基-6-甲基吡啶 | CAS号10025-87-3 三氯氧磷 | CAS号134991-79-0 6-甲基-2,4-二(甲硫基)... | CAS号134992-24-8 6-甲基-2,4-二(甲硫基)... | CAS号179056-94-1 2-氯-4-甲氧基-6-甲基-... | CAS号179056-98-5 2,4-二氯-6-甲基吡啶-3-胺 | CAS号754989-43-0 6-methyl-3-nitr... | CAS号870135-16-3 2-氯-N4,6-二甲基-3,... | CAS号870135-17-4 4-氯-1,6-二甲基-1H-... | CAS号870135-18-5 2-溴-4-氯-1,6-二甲基...

合成工艺路线路线简述

  • 合成目标产物 2,4-Dichloro-6-Methyl-3-Nitropyridine 主要起始原料 2,4-Dihydroxy-6-Methylpyridine
  • (文献来源)合成步骤主要原料 2,4-Dihydroxy-6-Methylpyridine
4-羟基-6-甲基-2-吡喃酮置于ammonium Hydroxide,硝酸,三乙胺,Sodium Nitrite,三氯氧磷体系中,用 溶剂黄146 作为反应溶剂,化学反应 7.5H,反应生成 2,4-二氯-6-甲基-3-硝基吡啶
参考文献:4-叠氮基-3-硝基吡啶热环化成呋喃烷†
标题:4-叠氮基-3-硝基吡啶热环化成呋喃烷†
摘要:在硝化和氯化后从4-羟基-2-吡啶酮1和8中获得的4-氯-3-硝基-2-吡啶3和10与叠氮化钠一起得到4-叠氮基3-硝基吡啶4和11,在热解为呋喃烷6和12.用三苯基膦将呋喃喃6脱氧,得到呋喃山7.通过差示扫描量热法(dsc)研究了叠氮化物4的热分解条件和6至7的脱氧反应.
DOI:10.1002/jhet.5570370537

海关参考信息

专利信息


专利号:EP-0609960-B1
优先权日:1989-09-15
标 题 :New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase
发明人:MCCARTHY PETER A; HAMANAKA ERNEST S; WALKER FREDERICK J; CHANG GEORGE; TRUONG THIEN
权利人:PFIZER
摘要:Compounds of the formula the pharmaceutically acceptable salts thereof, wherein Q and R<1> are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.

专利号:US-5656634-A
优先权日:1991-03-21
标题 :N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
发明人:CHANG GEORGE; HAMANAKA ERNEST S; MCCARTHY PETER A; TRUONG THIEN V; WALKER FREDERICK J
权利人:PFIZER
摘要:Compounds of the formula ##STR1## the pharmaceutically acceptable salts thereof, wherein Q and R 1 are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.

专利号:US-7459552-B2
优先权日:2003-05-28
标 题:Method for producing cyclic diamine derivative or salt thereof
发明人:SHIBUYA KIMIYUKI; OHGIYA TADAAKI; MIURA TORU
权利人:KOWA CO
摘要:The present invention is directed to a method for producing a cyclic diamine compound (3) or a salt thereof through the following scheme: n n(wherein Ar represents a phenyl group, a pyridyl group, or a pyrimidinyl group, any of which may have a substituent; X represents NH, S, or O; ring A represents a benzene ring or a pyridine ring, which may have a substituent; 1 represents an integer of 1 or 2; m represents an integer of 1 or 2; and n represents an integer of 1 to 6). The method enables synthesis of a cyclic diamine compound (3) or a salt thereof, which serves as an ACAT inhibitor, in an industrially useful manner.

专利号:US-5596001-A
优先权日:1993-10-25
标题 :4-aryl-3-(heteroarylureido)quinoline derivatves
发明人:HAMANAKA ERNEST S
权利人:PFIZER
摘要:Compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , m, X and Q are as defined below, and novel intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and natiatherosclerosis agents.

专利号:NO-333799-B1
优先权日:2003-07-07
标 题:Intermediate for the synthesis of 2,4-bis (trifluoroethoxy) pyridine compounds
济南恒茂医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jnhengmaoyy.com/
电话: 0531-88262980 13156180564👤
📞济南恒茂医药科技有限公司 ⚠️参考联系方式

销售电话:0531-88262980 13156180564
邮箱:jnhengmao@163.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Mérour, J.-Y.; Joseph, B., Science of Synthesis Knowledge Updates, (2016) 3, 106.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知